ABBV logo AbbVie +
AbbVie
+

AbbVie (ABBV) Business News

Track AbbVie in real time with a live news feed covering AbbVie stock news, official press releases, company announcements, and an archive of historical AbbVie news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
1:41 PM | Friday | May 15, 2026 Zacks Investment Research

Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?

News Thumbnail
12:01 PM | Friday | May 15, 2026 Zacks Investment Research

How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?

News Thumbnail
11:40 AM | Friday | May 15, 2026 24/7 Wall Street

Realty Income Has Raised Its Dividend 113 Consecutive Times. Here Is Why That Is Not Enough to Own It Right Now

News Thumbnail
12:01 PM | Friday | May 15, 2026 Zacks Investment Research

How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?

News Thumbnail
11:40 AM | Friday | May 15, 2026 24/7 Wall Street

Realty Income Has Raised Its Dividend 113 Consecutive Times. Here Is Why That Is Not Enough to Own It Right Now

News Thumbnail
7:15 AM | Wednesday | May 13, 2026 Zacks Investment Research

The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio

News Thumbnail
10:30 AM | Tuesday | May 12, 2026 Seeking Alpha

AbbVie's Growth Engine Is Firing On All Cylinders

News Thumbnail
8:45 AM | Monday | May 11, 2026 Seeking Alpha

AbbVie Q1: Skyrizi Delivers, Here's What Skeptics Are Missing

News Thumbnail
10:08 AM | Saturday | May 9, 2026 MarketBeat

AbbVie Touts Record Sales and Pipeline Momentum at Annual Meeting

News Thumbnail
10:32 AM | Wednesday | May 6, 2026 24/7 Wall Street

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash

News Thumbnail
8:00 AM | Wednesday | May 6, 2026 PRNewsWire

AbbVie to Present at the Bank of America Securities Healthcare Conference

News Thumbnail
4:10 AM | Wednesday | May 6, 2026 The Motley Fool

Want Reliable Dividend Income in May? These 2 Stocks Deliver

News Thumbnail
10:01 AM | Tuesday | May 5, 2026 Zacks Investment Research

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?

News Thumbnail

Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?

Zacks Investment Research

1:41 PM | Friday | May 15, 2026

news photo
Loading...

AZN and ABBV both boast strong drug pipelines and growth outlooks, but differences in valuation, dividends and LOE risks set them apart.

Read full article redirect
1:41 PM | Friday | May 15, 2026

Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?

Zacks Investment Research

AZN and ABBV both boast strong drug pipelines and growth outlooks, but differences in valuation, dividends and LOE risks set them apart.

Read full article arrow
News Thumbnail
12:01 PM | Friday | May 15, 2026

How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?

Zacks Investment Research

ABBV's Q1 beat is powered by Skyrizi and Rinvoq, whose strong sales growth offset Humira declines and boosts 2026 guidance.

Read full article arrow
News Thumbnail
11:40 AM | Friday | May 15, 2026

Realty Income Has Raised Its Dividend 113 Consecutive Times. Here Is Why That Is Not Enough to Own It Right Now

24/7 Wall Street

Realty Income (

Read full article arrow
News Thumbnail
12:01 PM | Friday | May 15, 2026

How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?

Zacks Investment Research

ABBV's Q1 beat is powered by Skyrizi and Rinvoq, whose strong sales growth offset Humira declines and boosts 2026 guidance.

Read full article arrow
News Thumbnail
11:40 AM | Friday | May 15, 2026

Realty Income Has Raised Its Dividend 113 Consecutive Times. Here Is Why That Is Not Enough to Own It Right Now

24/7 Wall Street

Realty Income (

Read full article arrow
News Thumbnail
7:15 AM | Wednesday | May 13, 2026

The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio

Zacks Investment Research

AI demand and pipeline growth headline top Zacks stock reports on NVIDIA, Mastercard and AbbVie.

Read full article arrow
News Thumbnail
10:30 AM | Tuesday | May 12, 2026

AbbVie's Growth Engine Is Firing On All Cylinders

Seeking Alpha

AbbVie is a compelling 'Buy' as it has strong momentum in existing drugs and has a robust pipeline. Robust Q1 2026 results: net revenue up 12.4% YoY, driven by Immunology (Skyrizi +29%, Rinvoq +20%) and Neuroscience (+24%). Management raised 2026 EPS guidance to $14.18, signaling 42% YoY growth and confidence in ABBV's diversified growth drivers and pipeline.

Read full article arrow
News Thumbnail
8:45 AM | Monday | May 11, 2026

AbbVie Q1: Skyrizi Delivers, Here's What Skeptics Are Missing

Seeking Alpha

AbbVie (ABBV) delivered strong Q1 2026 results, with $15B revenue (+12.4% YoY) and Skyrizi sales up 30.9%, prompting raised EPS guidance. Despite analyst concerns over new oral competitors like Icotyde, Skyrizi maintains a clear efficacy advantage and expanding indications, supporting robust growth. ABBV is trading at 14.
2x 2026 EPS with a 0.84x PEG, offering compelling value amid 17% projected earnings growth and a $250/share price target.

Read full article arrow
News Thumbnail
10:08 AM | Saturday | May 9, 2026

AbbVie Touts Record Sales and Pipeline Momentum at Annual Meeting

MarketBeat

AbbVie NYSE: ABBV told shareholders at its annual meeting that 2025 was “another excellent year” for the company, citing record sales, stronger-than-expected revenue and continued investment in its drug pipeline and business development.

Read full article arrow
News Thumbnail
10:32 AM | Wednesday | May 6, 2026

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash

24/7 Wall Street

Dividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities remain the cleanest source outside a paycheck.

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | May 6, 2026

AbbVie to Present at the Bank of America Securities Healthcare Conference

PRNewsWire

NORTH CHICAGO, Ill., May 6, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 13, 2026.

Read full article arrow
News Thumbnail
4:10 AM | Wednesday | May 6, 2026

Want Reliable Dividend Income in May? These 2 Stocks Deliver

The Motley Fool

AbbVie is a Dividend King that has proven its ability to adapt. Realty Income is the ultimate monthly income play.

Read full article arrow
News Thumbnail
10:01 AM | Tuesday | May 5, 2026

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?

Zacks Investment Research

AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article arrow
News Thumbnail